Global In-vitro Diagnostics Market 2019-2023 | Technological Advances in In-vitro Diagnostics to Boost Growth | Technavio

Technavio has released a new market research report on the global in-vitro diagnostics market for the period 2019-2023. (Graphic: Business Wire)

LONDON--()--The global in-vitro diagnostics market is expected to post a CAGR of close to 7% during the period 2019-2023, according to the latest market research report by Technavio.

A key factor driving the growth of the global in-vitro diagnostics market is the high demand for personalized medicine. The growing focus on next-generation sequencing for genetic mapping of patients, companion diagnostics, whole genome technology, increasing use of combination biomarkers for diagnostics is fueling the growth of the personalized medicine market. With researchers and diagnostic companies seeking to develop diagnostic tests for therapeutic application fields such as cardio-renal, neurology, antiviral, pulmonary, and psychiatry, the demand for personalized medicines is expected to grow significantly during the forecast period.

This market research report on the global in-vitro diagnostics market 2019-2023 also provides an analysis of the most important trends expected to impact the market outlook during the forecast period. Technavio classifies an emerging trend as a major factor that has the potential to significantly impact the market and contribute to its growth or decline.

This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing

In this report, Technavio highlights the technological advances in in-vitro diagnostics as one of the key emerging trends in the global in-vitro diagnostics market:

Global in-vitro diagnostics market: Technological advances in in-vitro diagnostics

Over the years, there have been significant advances in healthcare technology that has transformed patient care worldwide. By incorporating next-generation tabletop and hand-held diagnostics that work on genes, the in-vitro diagnostics market is witnessing immense technological advancements. Advanced cutting-edge technologies like point-of-care testing, next-generation sequencing, near patient testing, increased automation, hospital laboratory management, and customer relationship management have revolutionized the in-vitro diagnostics sector by providing an accurate and precise diagnosis at rapid rates.

“Apart from the high demand for personalized medicine, factors such as the increasing geriatric population, chronic, and infectious diseases, and the industrial development are expected to positively impact the growth of the global in-vitro diagnostics market during the forecast period,” says a senior analyst at Technavio.

Global in-vitro diagnostics market: Segmentation analysis

This market research report segments the global in-vitro diagnostics market by technology (immunochemistry, molecular diagnostics, tissue diagnostics, and hematology), and geographical regions (APAC, EMEA, and the Americas).

The Americas region led the market in 2018 with a market share of over 44%, followed by EMEA and APAC respectively. Although the APAC region held the smallest market share in 2018, it is expected to register the highest incremental growth during the forecast period.

Looking for more information on this market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

Market Sizing

  • Market definition
  • Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

  • Regional comparison
  • Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Competitive scenario

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com

Release Summary

The global in-vitro diagnostics market is expected to post a CAGR of close to 7% during the period 2019-2023, according to Technavio.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com